EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...
This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...
EU antitrust regulators are soliciting feedback from competitors and customers regarding Novo Holdings' proposed $16.5 ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...
GSK is carving out a niche for Blenrep in the second-line multiple myeloma setting, for which it projects multi-blockbuster ...
New cGMP fermentation facility in the UK set to meet growing demand for drug substance production, supporting biopharma ...
The European Commission is asking biopharma and manufacturing companies about their reaction to Novo ...
The "Thematic Intelligence: Rare Disease" report has been added to ResearchAndMarkets.com's offering.In recent years, there has been growing recognition of the importance of rare diseases as a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback